bersiporocin (DWN12088) - Daewoong Pharma, Biocon
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF (clinicaltrials.gov) - Jul 17, 2026 - P2 | N=102 | Active, not recruiting | Sponsor: Daewoong Pharmaceutical Co. LTD. | Recruiting ➔ Active, not recruiting 
Enrollment closed • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
http://clinicaltrials.gov/ct2/show/NCT05389215
 
Jul 17, 2026
 
Prev Next